FDA warns against off-label use of ketoconazole oral tablets

被引：0
作者：
机构：
来源：
Reactions Weekly | 2016年 / 1604卷 / 1期
关键词：
D O I：
10.1007/s40278-016-18059-9
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3 / 3
相关论文
共 50 条
  • [41] QUETIAPINE OFF-LABEL USE
    Levin, R.
    Cosmatos, I
    Dieck, G.
    Reifsnyder, J.
    VALUE IN HEALTH, 2016, 19 (07) : A522 - A522
  • [42] Off-label use in neurology
    Diener, HC
    AKTUELLE NEUROLOGIE, 2002, 29 (08) : 379 - 381
  • [43] DexamethasoneCataract and off-label use
    Reactions Weekly, 2024, 2008 (1) : 128 - 128
  • [44] Off-Label Use Reimbursement
    Cohen, Joshua
    Wilson, Andrew
    Faden, Laura
    FOOD AND DRUG LAW JOURNAL, 2009, 64 (02) : 391 - 403
  • [45] FDA publishes final rule on off-label information
    Barlas, S
    ONCOLOGY-NEW YORK, 1999, 13 (02): : 150 - 150
  • [46] From off-label prescribing towards a new FDA
    Tabarrok, Alex
    MEDICAL HYPOTHESES, 2009, 72 (01) : 11 - 13
  • [47] ‘Off-label’ drug use: an FDA regulatory term, not a negative implication of its medical use
    W A Meadows
    B D Hollowell
    International Journal of Impotence Research, 2008, 20 : 135 - 144
  • [48] Off-Label Use vs Off-Label Marketing of Drugs Part 1: Off-Label Use-Patient Harms and Prescriber Responsibilities
    Van Norman, Gail A.
    JACC-BASIC TO TRANSLATIONAL SCIENCE, 2023, 8 (02): : 224 - 233
  • [49] 'Off-label' drug use: an FDA regulatory term, not a negative implication of its medical use
    Meadows, W. A.
    Hollowell, B. D.
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2008, 20 (02) : 135 - 144
  • [50] Prevalence of Off-Label Use of Oral Oncolytics at a Community Cancer Center
    Kalis, Joseph A.
    Pence, Simon J.
    Mancini, Robert S.
    Zuckerman, Dan S.
    Ineck, Joseph R.
    JOURNAL OF ONCOLOGY PRACTICE, 2015, 11 (02) : E139 - E143
12345